Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
Baxter
G F
GF
The Hatter Institute, University College London, London. gfbaxter@rvc.ac.uk
Ebrahim
Z
Z
D000626:Aminopeptidases / Q000037:antagonists & inhibitors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D019898:Autocrine Communication; D001920:Bradykinin / Q000096:biosynthesis / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial; D017202:Myocardial Ischemia / Q000378:metabolism* / Q000517:prevention & control; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000517:prevention & control; D015260:Neprilysin / Q000037:antagonists & inhibitors; D019899:Paracrine Communication
D000806:Angiotensin-Converting Enzyme Inhibitors; D000626:Aminopeptidases; C022750:X-Pro aminopeptidase; D015260:Neprilysin; D001920:Bradykinin